Updates to the Varicella-Zoster Virus Section of the Pediatric Opportunistic Infections Guidelines

 

 

 

	OFFERING INFORMATION ON HIV/AIDS TREATMENT, PREVENTION, AND RESEARCH
	At-a-Glance   Issue No. 30 | December 9, 2019 View HTML version     News and Features Updates to the Varicella-Zoster Virus Section of the Pediatric Opportunistic Infections Guidelines The Varicella-Zoster Virus section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children has been updated. The Panel updated this section to include new information on VariZIG, which is now readily available for passive immunization when indicated. Additional evidence now supports protection by VariZIG when administered within 10 days of exposure to varicella-zoster virus (VZV). The section has also been updated to reflect the new recommendation rating system and references were added.             Home | Guidelines | Understanding HIV/AIDS | Drugs | Clinical Trials | Research Contact Us

 

---

You are subscribed as myhcistech.healthnews360@blogger.com. Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the GovDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.

This service is provided to you at no charge by AIDSinfo.

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: AIDSinfo · P.O. Box 4780· Rockville, MD 20849-6303